Status | Study |
Recruiting |
Study Name: Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122) Condition: Nasopharyngeal Neoplasms Date: 2015-11-19 Interventions: Biological: Pembrolizumab IV i |
Completed |
Study Name: A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer Condition: Nasopharyngeal Cancer Date: 2015-11-16 Interventions: Drug: Capecitabine Participant |
Recruiting |
Study Name: Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China Condition: Nasopharyngeal Cancinoma (NPC) Date: 2015-10-23 |
Recruiting |
Study Name: Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma. Condition: Nasopharyngeal Neoplasms Mortality Quality of Life Date: 2015-05-25 Interventions: Radiation: Hyperfractionated IMRT Radiatio |
Enrolling by invitation |
Study Name: A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Date: 2015-04-07 Interventions: Drug: endostar Other Name: Hum |
Recruiting |
Study Name: Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Blood Cell Count Neoplasm Staging Date: 2014-08-05 |
Completed |
Study Name: PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae Condition: Streptococcal Pneumonia Nasopharyngeal Diseases Date: 2014-05-07 Interventions: Biological: PCV7 (Pneumococcal 7-Valent Conjugate Vaccine) |
Completed |
Study Name: T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC Condition: Head and Neck Cancer Date: 2008-02-02 Interventions: Biological: autologous EBV specific CTLs 30-40cc of periph |
Active, not recruiting |
Study Name: Family Study of Head and Neck Cancers in Taiwan Condition: Nasopharyngeal Neoplasms Herpesvirus 4, Human Date: 2006-06-19 |
Completed |
Study Name: A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations Condition: Mouth Cancer Lip Cancer Throat Cancer Date: 2005-09-13 |